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Abstract
Background: Limited capacity of laboratories for antimicrobial susceptibility testing (AST) presents a critical
diagnostic bottleneck in resource limited countries. This paper aims to identify such gaps and to explore whether
laboratory networks could contribute towards improving AST in low resource settings.
Methods: A self-assessment tool to assess antimicrobial susceptibility testing capacity was administered as a
pre-workshop activity to participants from 30 microbiology laboratories in 3 cities in Pakistan. Data from public and
private laboratories was analyzed and capacity of each scored in percentage terms. Laboratories from Karachi were
invited to join a support network. A cohort of five laboratories that consented were provided additional training
and updates sessions over a period of 15 months. Impact of training activities in these laboratories was evaluated
using a point scoring (0-11) tool.
Results: Results of self-assessment component identified a number of areas that required strengthening (scores of
≤60%). These included; readiness for AMR surveillance; 38 and 46%, quality assurance; 49 and 55%, and detection of
specific organisms; 56 and 60% for public and private laboratories respectively. No significant difference was detected
in AST capacity between public and private laboratories [ANOVA; p > 0.05]. Scoring tool used to assess impact of
training within the longitudinal cohort showed an increase from a baseline of 1-5.5 (August 2015) to improved post
training scores of 7-11 (October 2016) for the 5 laboratories included. Moreover, statistical analysis using paired t-Test
Analysis, assuming unequal variance, indicated that the increase in scored noted represents a statistically significant
improvement in the components evaluated [p < 0.05].
Conclusion: Strengthening of laboratory capacity for AMR surveillance is important. Our data shows that close
mentoring and support can help enhance capacity for antimicrobial sensitivity testing in resource limited settings.
Our study further presents a model wherein laboratory networks can be successfully established and used towards
improving diagnostic capacity in such settings.
Keywords: Antimicrobial susceptibility testing, Laboratory capacity, Surveillance for antimicrobial resistance
* Correspondence: rumina.hasan@aku.edu
1Department of Pathology and Laboratory Medicine, Aga Khan University
Hospital, Stadium Road, PO Box 3500, Karachi 74800, Pakistan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Saeed et al. Antimicrobial Resistance and Infection Control  (2017) 6:101 
DOI 10.1186/s13756-017-0260-6
Background
A multi-sectorial problem, encompassing both environ-
ment and health related activities, successful contain-
ment of antimicrobial resistance (AMR) requires
informed horizontal as well as vertical interventions [1],
underpinned by an effective surveillance system [2, 3].
Countries that have managed to control or curtail resist-
ance rates are those that have been able to implement a
functional surveillance system; there by enabling them
to gather reliable and accurate data on resistance trends
as well as to monitor temporal shifts in resistance and
implement strategies accordingly.
While surveillance includes several components; sus-
ceptibility reporting, data management and analysis [4],
standardized and reliable laboratory practices is integral
to establishing AMR surveillance, as exemplified by
Sweden where the successful establishment of surveil-
lance programs was underscored by the existence of op-
erational and well-equipped microbiological diagnostic
laboratories [5]. On the other hand, in resource limited
countries (RLCs) a dearth of standardized microbiology
laboratories hampers the establishment of such a system.
The significance of the microbiology diagnostic labora-
tory is not limited to surveillance, but also extends to
other AMR curtailing strategies including antimicrobial
stewardship and infection control practices. Denning et al.
[6] present a very strong case for improving diagnostic
capacity of laboratories by elucidating the relationship be-
tween misdiagnosis and inappropriate use of antibacterials
and antifungals arising from a lack of fungal diagnostic
capacity in laboratories. Subsequently, upending efforts
made by antibacterial stewardships programs to control
resistance. Poor communication between physician and
clinical microbiologists in a centralized laboratory system,
was acknowledged to undermine infection control efforts
[7]. Additionally, poor access to quality assured suscepti-
bility testing resulting in a preference for emperical and
combination therapies further contributes towards
increasing resistance within the population. Therefore,
capacity building of laboratories can also further the case
for implementing antimicrobial conservation practices in
low and middle income countries (LMICs). Currently,
Pakistan is in the process of implementing Global Anti-
microbial Surveillance System (GLASS) [8]. Pakistan’s
AMR capabilities have been identified to require urgent
attention with regards to strengthening infrastructure of
diagnostic laboratories in public health and animal health
sector [9].
A number of publications [10–12] have discussed
AMR capacity building in resource limited settings
(RLS) and addressed strengthening laboratories’ capacity
as part of the objectives for establishing proper surveil-
lance systems in these countries. While, studies have
been carried out that explore laboratory capacity to diag-
nose specific organisms [13] for control of neglected
tropical diseases [14], there is a dearth of literature in-
vestigating existing gaps in AST proficiency testing in
RLCs. Such gaps hinder implementation of an effective
and sustainable surveillance system. The study presented
evaluates laboratory capacity and gaps in both public
and private sector laboratories in Pakistan. Knowledge-
based interventions were introduced in selected cohort
laboratories from Karachi along with periodic on-site
visits of the laboratories to evaluate impact of these
interventions.
Methods
Capacity for antimicrobial susceptibility (AST) in Karachi
and gaps were evaluated and identified by collecting and
reviewing previous data and reports on this topic. A ques-
tionnaire based on the SLIPTA checklist [15], WHO AMR
surveillance: questionnaire for assessment of national
network [16], and WHO guide for establishing laboratory-
based surveillance for antimicrobial resistance [12] was
then developed. The questionnaire (Additional file 1)
included the following 9 components for evaluating
laboratory capacity; use of standardized methods, stan-
dardized operating procedures (SOPs), quality assurance,
readiness for AMR surveillance, testing for specific organ-
isms, equipment maintenance, technical capacity of staff,
infrastructure and laboratory biosafety. This questionnaire
was administered as part of a pre-workshop self-
assessment questionnaire in three major cities of Pakistan;
Karachi (March, 2015), Lahore (September, 2016) and
Peshawar (August 2016). Participants from 30 laboratories
participated in this exercise (Table 1). Scoring of responses
was as follows; Yes: 1, Partial: 0.5, and No: 0.
Table 1 Laboratories participating in self-assessment exercise (n = 30)
Laboratories Karachi Peshawar Lahore
Private Public Private Public Private Public
Tertiary care/teaching hospital 2 5 4 2 1 8
General hospital 2 1
Commercial diagnostic laboratories 1 1 1
Research laboratories 1 1
Total 5 7 5 3 2 8
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Percentage scores were then calculated for each ques-
tion and categories. The percentage score for each cat-
egory was calculated as the sum of components scores
obtained for the category expressed as a percentage of the
maximum score expected for that category based on num-
ber of responses (Additional file 2). Where there were
more than one participants from a particular laboratory,
and the scores for individual components were different,
the lower score was entered for that question. This was on
the assumption that discrepancy highlights deficiency in
practices and thus a gap. Interpretation of the results was
as follows; response < 50%: significant improvement
required, > 50 to < 80%: some improvement required,
response > 80%: laboratory is in good standing.
The laboratories from Karachi were subsequently in-
vited to participate in a 2 years follow-up project
wherein further training and guidance was offered
through additional workshops and on-site visits. Based
on informed consent cohort of five laboratories from
Karachi were identified; 4/5 laboratories were from the
public sector; (3 tertiary-care hospital and one research
laboratory). The remaining fifth laboratory was from the
private sector. Subsequently, a bi-pronged approach in-
volving knowledge strengthening and follow-up on-site
visits were carried out on regular basis as part of cap-
acity strengthening strategy. Activities organized for
strengthening laboratory capacity in this cohort are
enlisted in Table 2. In addition the staff of the cohort
laboratories were encouraged to visit or make phone
contact if clarifications or help with problem solving was
required. To assess impact of the knowledge based inter-
ventions, on-site laboratories assessment was carried out
at 3 time points during the follow-up period. An evalu-
ation tool (Additional file 3) was used. Responses were
scored as follows; Yes: 1, Partial: 0.5 and No: 0. Total
score of each laboratory was calculated and used as a
measure of impact over time.
Data analysis
Statistical difference between public and private labora-
tories’ capacity for AST was determined by one-way
ANOVA of the percentage scores for the assessed
categories.
Aggregated scores from post workshop evaluations of
the Karachi laboratories at time points 1 and 3 were ana-
lyzed using paired t-Test assuming unequal variances, to
determine whether the impact of knowledge based inter-
ventions coupled with on-site visits was statistically
significant.
Results
Results of the pre-workshop self-assessment question-
naire show the gaps documented in the nine categories
evaluated Fig. 1 (Additional file 2). Performance of both
public and private laboratories in the different categories
assessed was surprisingly similar. One way ANOVA
[p = 0.953] revealed that no significant disparity existed
in the capacity between public and private labs to carry
Table 2 Knowledge based capacity strengthening activities for cohort laboratories
DATE ACTIVITIES
July 2015 Groups meeting with cohort laboratories that had earlier submitted their consent
form to discuss project details and activity plans.
August 2015 Cohort laboratories visited for base-line needs assessment. Evaluation tool administered
August 2015 Gaps and solutions to address deficiencies discussed with cohort laboratories.
Topics for training sessions finalized
September- November 2015 Training sessions Preparation of SOPs
Using on-line resources including ASM resources
Principles of AST’s
Update on McFarland SOPs
Practical session Preparation of McFarland Standards
Training sessions Quality Control of AST media
Storage of QC strains
Workshop Minimum Inhibitory Concentration (MIC) for
Antimicrobial Sensitivity Testing
March 2016 Laboratory strengthening workshop Antimicrobial Resistance (AMR) Updates
June 2016 Post-workshop audit of cohort laboratories conducted and evaluation tool administered.
Gaps noted and laboratory workers counseled accordingly.
October 2016 Follow up of cohort laboratories conducted to evaluate improvements and persisting
gaps using evaluation tool. Laboratory workers counseled accordingly.
December 2016 Workshops held in parallel; Infection control
Antimicrobial susceptibility testing of Fastidious organisms
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out standardized AST. The majority of areas assessed
scored between 50 and 80% (i.e. some improvement re-
quired). Both public and private sector laboratories
scored well in biosafety areas assessed i.e. hand hygiene
and incineration. However, for incineration/autoclaving
prior to waste disposal; private sector laboratories scored
58% while public sector labs scored 79% (Add-
itional file 2). Performance in both private and public
sector laboratories was < 60% for quality assurance, and
detection of specific organisms. Infrastructural standing
of public labs (60%) was comparatively lower than pri-
vate labs (72%), with unavailability of automated systems
as a significant gap in both public (0%) and private labs
(25%). While a score of under 50% (i.e. significant im-
provement required) was achieved for readiness for
AMR surveillance, few laboratories generated routine
antibiograms; 38 and 53% score for private and public
laboratories respectively (Additional file 2). Specific gaps
identified in terms of quality assurance included lack of
quality control of susceptibility discs and antimicrobial
disc potency, non-availability of standard guidelines in
the procedure manuals for inconsistent AST results, and
the need for participation in internal and external quality
assurance programs (Additional file 2).
Amongst the laboratory cohort from Karachi, the ini-
tial on-site visits conducted after the workshop, revealed
that the impact of the workshop was limited and that
the participant laboratories only partially succeeded in
implementing practices communicated during the work-
shops. Contributory factors included lack of resources
e.g. access to standardized quality control strains for
AST. Implementation of quality controls for media and
antimicrobial sensitivity testing were also incomplete.
The laboratories were not participating in external qual-
ity control program. Furthermore waste was not being
safely disposed. In view of these observations, additional
workshops, training and discussion sessions were orga-
nized for this group (Table 2).
During the course of the study period, encouraging
progress was recorded in the cohort laboratories from
baseline score of ranges of 1-5.5 in August 2015 to 7-11
in October 2016 (Fig. 2). Paired t-Test, assuming un-
equal variance, of laboratory evaluation scores at time
points 1 and 3 indicated statistically significant progress
[p = 0.00518, t Stat = −4.2841] for four of the five cohort
labs (the 5th lab was only visited at 2 time points).
Changes implemented in these laboratories included; de-
velopment and implementations of SOPs, quality assur-
ance for AST, compliance with waste disposal protocols,
and greater use of on-line materials including American
Society of Microbiology (ASM) resources. Two labora-
tories furthermore started incorporating susceptibility
data into an antibiogram. During this period 2 of the la-
boratories also began to participate in a national external
quality assurance program.
Discussion
Pakistan has a mixed public-private health care system.
The public health sector comprises of a three tiered
structure; primary (basic health units), secondary (tehsil
and district hospitals) and tertiary (tertiary hospitals)
care [17]. Due to limited spending on health by the
government [18] monetary and personnel resources
required to establish and maintain standardized labora-
tory practices are insufficient. Furthermore, with 86.8%
[19] of health related expenses borne out of pocket,
many resort to health services provided by the private
sector. Laboratories from both public and private sector
included in our study scored either < 50% (requiring
significant improvement) or between 50-80% (needing
Fig. 1 Self-assessment scores for private and public laboratories for the categories used to evaluate AST capacity. Key; USM = Use of standardized
methods, SOP = Standard Operating Procedure, QA = Quality Assurance, EM = Equipment Maintenance, RAS = Readiness for AMR surveillance,
SO = Specific organisms, Staf = Staffing, Infr = Infrastructure, Bio = Biosafety
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some improvement) in 7 of the 9 categories evaluated.
In particular limited use of quality control (QC) strains
and standardized inoculum are pertinent gaps that
undermine the reliability and reproducibility of AST
being carried out. Additionally uninterrupted power
supply in the public sector laboratories is a significant
gap to be circumvented for improving laboratory infra-
structure. These findings are consistent with earlier re-
ports [20–22]. Low participation in AMR surveillance,
a weak collaborative network between laboratories and
insufficient use of Laboratory Information Systems
(LIS) are underlying bottlenecks that need to be ad-
dressed in order to strengthen data collection, valid-
ation and aggregation of regional and national
resistance data. LIS in particular is recognized to not
only improve capacity for AMR surveillance through
the collation of data from different laboratories but to
also contribute towards standardization and improve-
ment of the quality control of methodology [23].
While an earlier knowledge and practices (KAP) sur-
vey from Pakistan reports considerable gaps between
awareness and implementation of standardized labora-
tory practices [24] comparatively higher scores of 54 and
72% for public and private laboratories, respectively,
indicated in our study, suggest that implementation of
SOPs has improved since the earlier KAP survey.
In resource limited healthcare settings where national
accrediting bodies exist, a higher percentage of accre-
dited laboratories have been observed to belong to the
private sector [25]. In such settings, private sector
laboratories, have the potential to assume a pivotal role
in combating AMR by partnering with public sector
laboratories and by participating in regional or national
surveillance to produce a clearer picture of resistance
trends [25]. In contrast, data from our study indicates
that participation in external quality assurance was weak
not only in public laboratories (46%) but also in the pri-
vate sector labs (38%). Paradoxically, despite a high par-
ticipation of public sector labs in internal quality
assurance programs (92%), prevalence of significant gaps
in these labs reiterates that internal quality assurance
can be more robust and effective when complimented
with an External Quality Assurance System (EQAS).
Knowledge based-interventions in the form of short
courses addressing specific diseases, along with skill
development have been proven to be effective models
for laboratory capacity building [11]. Consistent with
these findings, significant efforts by cohort laboratories
towards addressing gaps; development and implementa-
tion of SOPs regular use of standardized quality control
strains and standardized inoculum for AST emphasizes
the value of knowledge-based interventions towards ad-
dressing laboratory gaps. The success of proficiency test-
ing (PT) in conjunction with training programs has been
highlighted by a number of studies from resource lim-
ited settings [26–29]. The approach of partnering labora-
tories fulfilling core capacity with weaker labs suggests a
model of a sustainable network for knowledge and skill
transfer for RLCs. It has been suggested that such
partnering of laboratories may also contribute towards
reducing costs and increasing the range of diagnostic
facilities; enabling a robust laboratory system for surveil-
lance of infectious diseases [30]. Furthermore, tiered la-
boratory networks along with clearly defined national
guidelines that push for gearing lab capacity towards
national accreditation can achieve remarkable improve-
ments in laboratory diagnostic capacity for surveillance.
The initial part of our study relied on a self assessment
tool to evaluate laboratory capacity. An inherent draw-
back of this approach is that it could have been
Fig. 2 Score achieved by the cohort laboratories (1-5) at three time points. Lab 5 could only be visited at 2 time points
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influenced by individual bias as well as knowledge and
experience of the respondents. However, the fact that
the cohort laboratories were able to successfully address
many of their gaps was encouraging and suggests a
model wherein laboratory networks can be established
and leveraged towards improving diagnostic capacity in
resource limiting settings. It is important to note that
the role of the cohort laboratories leadership was essen-
tial for success of this model. The laboratory leadership
encouraged their staff to participate in training activities
and supported implementation of changes needed to ad-
dress identified gaps. Such facilitation was key in
strengthening of the laboratory network.
Conclusion
Our study illustrates that in resource constraint settings de-
veloping a laboratory network wherein laboratories that ful-
fill the International Health Regulation (IHR) core capacity
provide a central support role, providing didactic trainings
and workshops combined with long term follow-up and
mentoring can successfully strengthen laboratory capacity.
Additional files
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each category of laboratory capacity for both public and private sector are
also presented. Presents the scores including total percentage of public and
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